Autologous skin micro-grafts and allogenic skin allograft for mitten hand deformity treatment in epidermolysis bullosa
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20220365Keywords:
Epidermolysis bullosa, Soft-tissue defects, Treatment of mitten hand deformity, Combined auto-/allo-skin graft, Skin transplantationAbstract
Background: In the genetic skin blistering disorder dystrophic epidermolysis bullosa recurrent blisters and erosions on mechanically stressed areas, as the hands, result in subsequent scarring and development of pseudosyndactylies and contractures. In its most severe form, all fingers are constrained into a fist of scarred (“mitten-hand”-deformity). No causative therapy exists and only a surgical release of the fingers is possible. Hereby, the development of large skin defects is inevitable; the lack of healthy autologous skin for grafting remains a difficult challenge.
Methods: We propose a new technique: It adopts a treatment strategy from the therapy of large extent burns and consists of a combination of autogenic and allogenic skin grafting.
Results: We present a beneficial outcome in 18 mitten hand deformities treated with this technique. In all patients, the initial functional outcome was improved. Nearly all patients got a considerably widened grip span and durable skin conditions post-operatively. Mean follow-up was 3 years. Typically, recurrence of the scarring occurred from 6 months to 2 years after operation.
Conclusions: This is the first report on the use of the combination of autogenous pinch skin grafts with allogenic (parental) skin overlay for skin defects in EB. It provides undisturbed wound healing under a “biological dressing”, furthermore, a temporary take of the parental skin was visible. Defects were permanently covered with skin of increased mechanical stability, hand function improved remarkably. However, long term follow-up showed beginning recurrence in most of the patients comparable to recurrence rates described in the literature.
Metrics
References
Fine JD, Johnson LB, Weiner M. Pseudosyndactyly and Musculoskeletal Contractures in Inherited Epidermolysis Bullosa: Experience of the National Epidermolysis Bullosa Registry, 1986-2002. J Hand Surg. 2005;30(1):14-22.
Kiritsi D, Nyström A. Recent advances in understanding and managing epidermolysis bullosa. F1000 Research. 2018;7.
Tuncer S, Sezgin B, Kaya B, Ayhan S, Latifoglu O. An algorithmic approach for the management of hand deformities in dystrophic epidermolysis bullosa. J Plast Surg Hand Surg. 2018;52(2):80-6.
Diedrichson J, Talanow D, Safi A. Epidermolysis bullosa dystrophica (Hallopeau-Siemens syndrome) of the hand surgical strategy and results. Handchir Mikrochir Plast Chir. 2005;37(5):316-22.
Ladd AL, Kibele A, Gibbons S. Surgical treatment and postoperative splinting of recessive dystrophic epidermolysis bullosa. J Hand Surg. 1996;21(5):888-97.
Cuono CB, Langdon R, Birchall N, Barttelbort S, McGuire J. Composite autologous-allogeneic skin replacement: development and clinical application. Plast Reconstr Surg. 1987;80(4):626-37.
Jutkiewicz J, Noszczyk BH, Wrobel M. The use of Biobrane for hand surgery in Epidermolysis bullosa. J Plast Reconstr Aesthetic Surg JPRAS. 2010;63(8):1305-11.
Chih-Chun Y, Tsi-Siang S, Te-An C, Wei-Shia H, Shou-Yen K, Yen-Fei C. The intermingled transplantation of auto- and homografts in severe burns. Burns. 1980;6(3):141-5.
Alexander JW, MacMillan BG, Law E, Kittur DS. Treatment of severe burns with widely meshed skin autograft and meshed skin allograft overlay. J Trauma. 1981;21(6):433-8.
Horch RE, Stark GB, Spilker G. Behandlung der perianalen Verbrennungen und chronischen Ulzera durch versenkte Hautpartikel. Zentralbl Chir. 1994;119:722-5.
Kistler D, Hafemann B, Hettich R. Morphological changes of intermingled skin transplants on rats. Burns Incl Therm Inj. 1988;14(2):115-9.
Kiritsi D, Garcia M, Brander R. Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa. J Invest Dermatol. 2014;134(8):2097-104.
Moss C, Wong A, Davies P. The Birmingham Epidermolysis Bullosa Severity score: development and validation. Br J Dermatol. 2009;160(5):1057-65.
Phipps AR, Clarke JA. The use of intermingled autograft and parental allograft skin in the treatment of major burns in children. Br J Plast Surg. 1991;44(8):608-11.
Qaryoute S, Mirdad I, Hamail AA. Usage of autograft and allograft skin in treatment of burns in children. Burns J Int Soc Burn Inj. 2001;27(6):599-602.
Coruh A, Tosun Z, Ozbebit U. Close relative intermingled skin allograft and autograft use in the treatment of major burns in adults and children. J Burn Care Rehabil. 2005;26(6):471-7.
Bruckner-Tuderman L, Mitsuhashi Y, Schnyder UW, Bruckner P. Anchoring fibrils and type VII collagen are absent from skin in severe recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 1989;93(1):3-9.
Horch R, Stark GB, Kopp J, Spilker G. Cologne Burn Centre experiences with glycerol-preserved allogeneic skin: Part I: Clinical experiences and histological findings (overgraft and sandwich technique). Burns. 1994;20:S23-6.
Stark GB, Kaiser HW. Cologne Burn Centre experience with glycerol-preserved allogeneic skin: Part II: Combination with autologous cultured keratinocytes. Burns. 1994;20:S34-8.
Horch RE, Corbei O, Formanek-Corbei B, Brand-Saberi B, Vanscheidt W, Stark GB. Reconstitution of basement membrane after ‘sandwich-technique’ skin grafting for severe burns demonstrated by immunohistochemistry. J Burn Care Rehabil. 1998;19(3):189-202.
Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med. 1990;172(5):1483-93.
Nagy N, Almaani N, Tanaka A. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol. 2011;131(8):1771-4.
Fritsch A, Loeckermann S, Kern JS. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest. 2008;118(5):1669-79.
Richters CD, Hoekstra MJ, Pont JS du, Kreis RW, Kamperdijk EWA. Immunology of skin transplantation. Clin Dermatol. 2005;23(4):338-42.
Sakabu SA, Hansbrough JF, Cooper ML, Greenleaf G. Cyclosporine A for prolonging allograft survival in patients with massive burns. J Burn Care Rehabil. 1990;11(5):410-8.
Eldad A, Benmeir P, Weinberg A. Cyclosporin A treatment failed to extend skin allograft survival in two burn patients. Burns J Int Soc Burn Inj. 1994;20(3):262-4.
Alsbjörn BF, Sørensen B. Grafting with epidermal Langerhans cell depressed cadaver split skin. Burns Incl Therm Inj. 1985;11(4):259-63.
Luria S, Radwan S, Zinger G, Eylon S. Hand surgery for dystrophic epidermolysis bullosa. J Pediatr Orthop. 2014;34(7):710-4.
Marín-Bertolín S, Amaya Valero JV, Neira Giménez C, Marquina Vila P, Amorrortu-Velayos J. Surgical management of hand contractures and pseudosyndactyly in dystrophic epidermolysis bullosa. Ann Plast Surg. 1999;43(5):555-9.
Terrill PJ, Mayou BJ, Pemberton J. Experience in the surgical management of the hand in dystrophic epidermolysis bullosa. Br J Plast Surg. 1992;45(6):435-42.
Vozdvizhensky SI, Albanova VI. Surgical treatment of contracture and syndactyly of children with epidermolysis bullosa. Br J Plast Surg. 1993;46(4):314-6.
Zhou X, Zhang Y, Zhao M. Surgical management of hand deformities in patients with recessive dystrophic epidermolysis bullosa. J Plast Surg Hand Surg. 2020;54(1):33-9.
Formsma SA, Maathuis CBG, Robinson PH, Jonkman MF. Postoperative hand treatment in children with recessive dystrophic epidermolysis bullosa. J Hand Ther Off J Am Soc Hand Ther. 2008;21(1):80-4.